The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 06, 2021
Filed:
Sep. 28, 2017
Applicant:
Bavarian Nordic A/s, Kvistgaard, DK;
Inventors:
Assignee:
Bavarian Nordic A/S, Kvistgaard, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 48/00 (2006.01); A61K 39/285 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C12N 15/863 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/00117 (2018.08); A61K 39/001182 (2018.08); C07K 14/4727 (2013.01); C07K 14/70525 (2013.01); C07K 14/70528 (2013.01); C07K 14/70532 (2013.01); C12N 15/863 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/545 (2013.01); A61K 2039/6031 (2013.01); C12N 2710/24143 (2013.01);
Abstract
Provided herein are recombinant poxviruses that are stable through successive passaging of the recombinant poxviruses. More particularly, the recombinant poxviruses comprise one or more modified nucleic acids encoding MUC1, CEA, and/or TRICOM antigens, wherein the recombinant poxviruses are stable through successive passaging. Also, provided herein are compositions and method related thereto.